About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

NCT01460160·128 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bristol-Myers Squibb

With

Children's Oncology Group
EsPhALL

Age

1–17

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Newly diagnosed Philadelphia chromosome positive Acute Lymphoblastic Leukemia (ALL)
Age \>1 year and \< less than 18 years old
Induction chemotherapy ≤ 14 days according to institutional standard of care
Adequate liver, renal and cardiac function

You may not be if

Prior treatment with a Oncogene fusion protein (BCR-ABL) inhibitor
Extramedullary involvement of the testicles
Active systemic bacterial, fungal or viral infection
Down syndrome

The record

StatusCompleted

PhasePhase 2

Taking part106

StartedApr 2012

UpdatedDec 8, 2021

Conditions

Leukemia, Pediatric

Where128

University Of Alabama At Birmingham
Birmingham, Alabama, United States
Phoenix Children'S Hospital/Ctr. For Cancer & Blood Ctr.
Phoenix, Arizona, United States
University Of Arkansas For Medical Sciences
Little Rock, Arkansas, United States

Clareo Health | Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia